[
  {
    "ticker": "BGD",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968891",
    "id": "02968891",
    "pages": 4,
    "price_sensitive": false,
    "date": "20250714",
    "time": "0856",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrscs5zflh4q.pdf",
    "summary": "<h3>Material Information Summary:</h3>\n<ul>\n<li><strong>Exploration Update</strong>:  </li>\n<li>Completed expedited soil sampling program over ~1.9km\u00b2 area at Tolmer high-grade silver discovery (South Australia).  </li>\n<li>~380 samples collected; assay results expected September 2025.  </li>\n<li>Follows expanded 2,882m RC drilling program (results pending).  </li>\n<li>Previous high-grade intersections include <strong>6m @ 4,747 g/t Ag</strong>, <strong>14m @ 434 g/t Ag</strong>, and <strong>4m @ 1,417 g/t Ag</strong>.  </li>\n</ul>\n<p>No capital markets or trading-specific actions (e.g., raising, halt, etc.) identified. Focus is on exploration progress.</p>",
    "usage": {
      "prompt_tokens": 2387,
      "completion_tokens": 143,
      "total_tokens": 2530,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:58:54.968819"
  },
  {
    "ticker": "IMU",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968890",
    "id": "02968890",
    "pages": 2,
    "price_sensitive": true,
    "date": "20250714",
    "time": "0856",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrs9m81xbkkz.pdf",
    "summary": "<ul>\n<li><strong>Trading Halt Request</strong>: Pending announcement of a proposed capital raising.  </li>\n<li><strong>Halt Duration</strong>: Until earlier of announcement release or normal trading on 16 July 2025.  </li>\n</ul>\n<p><em>(No other material information identified; excludes legal and administrative details).</em></p>",
    "usage": {
      "prompt_tokens": 721,
      "completion_tokens": 56,
      "total_tokens": 777,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T23:00:43.101483"
  },
  {
    "ticker": "GCM",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968889",
    "id": "02968889",
    "pages": 14,
    "price_sensitive": false,
    "date": "20250714",
    "time": "0854",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrs76spgm3xb.pdf",
    "summary": "<p><strong>Key Material Information Extracted:</strong></p>\n<ol>\n<li><strong>Market Validation</strong>  </li>\n<li>VHD graphite validated for superior thermal performance (300\u2013400W load vs. 200\u2013250W for legacy materials).  </li>\n<li>\n<p>Independent modeling by Prof. Qing Li (University of Sydney) confirms efficacy.  </p>\n</li>\n<li>\n<p><strong>Commercial Progress</strong>  </p>\n</li>\n<li>First production module operational, producing saleable VHD blocks.  </li>\n<li>\n<p>Active discussions with semiconductor OEMs, data centers (e.g., GreenSquareDC), and distributors (North America, Europe, APAC).  </p>\n</li>\n<li>\n<p><strong>Capital Markets Context</strong>  </p>\n</li>\n<li>Recent capital raise: <strong>$7M AUD</strong> (completed 02 June 2025).  </li>\n<li>\n<p>Market cap: <strong>$56M AUD</strong> (as of 10 July 2025).  </p>\n</li>\n<li>\n<p><strong>Near-Term Catalysts</strong>  </p>\n</li>\n<li>Prototype testing outcomes (high-performance electronics/data centers).  </li>\n<li>Preparation for sales agreements (target late 2025).  </li>\n<li>\n<p>Supply chain expansion in the USA (warehousing/logistics).  </p>\n</li>\n<li>\n<p><strong>Peer Comparison</strong>  </p>\n</li>\n<li>GCM positioned as production-stage vs. pilots (e.g., Novonix, Quantum Graphite).  </li>\n</ol>\n<p><strong>Omitted:</strong> Disclaimers, board details, historical data, non-material operational updates.  </p>\n<p><strong>Summary Type:</strong> Investor Update \u2192 Focused on technical validation, commercialization progress, and near-term revenue catalysts.</p>",
    "usage": {
      "prompt_tokens": 3278,
      "completion_tokens": 291,
      "total_tokens": 3569,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T23:00:04.472778"
  },
  {
    "ticker": "EGG",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968887",
    "id": "02968887",
    "pages": 1,
    "price_sensitive": false,
    "date": "20250714",
    "time": "0852",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrs2l5f2whxy.pdf",
    "summary": "<p><strong>Announcement Type: Executive Remuneration Clarification</strong>  </p>\n<ul>\n<li><strong>Correction:</strong> Ian Ball's long-term incentive (LTI) eligibility clarified \u2013 Performance Rights under the Enero Group Limited Rights Plan with a <strong>3-year performance period</strong>.  </li>\n<li><strong>LTI Structure:</strong>  </li>\n<li>Up to <strong>70% of fixed remuneration at target</strong>, <strong>140% at stretch</strong>, subject to performance conditions and Board approval.  </li>\n</ul>\n<p><strong>Purpose:</strong> Ensures market accurately informed on CEO compensation terms. No immediate trading impact.  </p>\n<p><em>No material capital markets/trading implications identified.</em></p>",
    "usage": {
      "prompt_tokens": 662,
      "completion_tokens": 115,
      "total_tokens": 777,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:59:19.684680"
  },
  {
    "ticker": "SCP",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968888",
    "id": "02968888",
    "pages": 2,
    "price_sensitive": true,
    "date": "20250714",
    "time": "0852",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrs4r3nkd3df.pdf",
    "summary": "<ul>\n<li><strong>Trading Halt Request</strong>: Pending announcement of a capital raising to fund an acquisition, working capital, and offer costs.  </li>\n<li><strong>Halt Duration</strong>: Until the earlier of normal trading on 16 July 2025 or announcement release.  </li>\n<li><strong>Capital Raising</strong>: Material to the company (structure/details not yet disclosed).  </li>\n</ul>\n<p>No further material information identified.</p>",
    "usage": {
      "prompt_tokens": 768,
      "completion_tokens": 76,
      "total_tokens": 844,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:59:58.183781"
  },
  {
    "ticker": "RNV",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968885",
    "id": "02968885",
    "pages": 2,
    "price_sensitive": false,
    "date": "20250714",
    "time": "0850",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrry2cq0lrzh.pdf",
    "summary": "<h3>Summary of ASX Announcement:</h3>\n<ul>\n<li><strong>Capital Raising Disclosure</strong>:  </li>\n<li><strong>Number of Shares Issued</strong>: 773,260 fully paid ordinary shares.  </li>\n<li><strong>Issue Price</strong>: $0.10741 per share (total ~$83k raised).  </li>\n<li><strong>Purpose</strong>: Notification under <strong>Section 708A(5)(e)</strong> of Corporations Act (issued without disclosure under Part 6D.2).  </li>\n</ul>\n<p><strong>No other material trading or capital markets information identified</strong>.  </p>\n<p><em>(Note: Boilerplate company background, clinical data, and market outlook omitted as non-material for immediate trading decisions.)</em></p>",
    "usage": {
      "prompt_tokens": 1173,
      "completion_tokens": 128,
      "total_tokens": 1301,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T23:00:23.670468"
  },
  {
    "ticker": "BRU",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968884",
    "id": "02968884",
    "pages": 14,
    "price_sensitive": true,
    "date": "20250714",
    "time": "0849",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrrvxgcz63lq.pdf",
    "summary": "<h3><strong>Buru Energy Limited \u2013 Quarterly Activities Report (30 June 2025) \u2013 Material Summary</strong></h3>\n<h4><strong>Key Highlights:</strong></h4>\n<ul>\n<li><strong>Rafael Gas Project (EP 428):</strong>  </li>\n<li>Strategic Development Agreement (SDA) signed with Clean Energy Fuels Australia (CEFA).  </li>\n<li>CEFA to finance, build, and operate an LNG plant (300 tonnes/day) at Rafael 1 well site.  </li>\n<li>Projected gross unrisked NPV: <strong>A$400 million</strong>; annual pre-tax cash flow: <strong>~A$70 million</strong>.  </li>\n<li>\n<p>Final Investment Decision (FID) targeted for <strong>mid-2026</strong>, production start by <strong>late 2027</strong>.  </p>\n</li>\n<li>\n<p><strong>Divestments:</strong>  </p>\n</li>\n<li>Sold 2H Resources Pty Ltd and non-core Canning Basin blocks to Koloma Australia.  </li>\n<li>Total consideration: <strong>up to A$2.0 million</strong> (A$1.0m upfront + A$1.0m contingent on milestones).  </li>\n<li>\n<p>Buru retains option to acquire <strong>30% interest</strong> in future hydrogen discoveries by 2H Resources.  </p>\n</li>\n<li>\n<p><strong>Financial Position (30 June 2025):</strong>  </p>\n</li>\n<li><strong>Cash balance: A$2.3 million</strong> (no debt).  </li>\n<li>Net cash outflow for quarter: <strong>A$3.2 million</strong> (operating: A$2.2m; investing: A$0.9m).  </li>\n<li>\n<p>Estimated funding runway: <strong>0.75 quarters</strong> (Note: Post-quarter, A$1.0m received from Koloma deal).  </p>\n</li>\n<li>\n<p><strong>Ungani Oilfield (L20/L21):</strong>  </p>\n</li>\n<li>Under care and maintenance; evaluating <strong>Mars prospect</strong> (9km north of Ungani) for farm-out.  </li>\n<li>Internal <strong>40% chance of success</strong> for Mars exploration.  </li>\n</ul>\n<h4><strong>Operational &amp; Strategic Focus:</strong></h4>\n<ul>\n<li>Primary focus on <strong>Rafael Gas Project</strong> as flagship development.  </li>\n<li>Rationalizing Canning Basin acreage (<strong>60% reduction in permit areas</strong>) to cut costs.  </li>\n</ul>\n<h3><strong>Appendix 5B Cash Flow Summary:</strong></h3>\n<ul>\n<li><strong>Q2 2025 Cash Outflows:</strong>  </li>\n<li>Exploration &amp; appraisal: <strong>A$2.3m</strong> (Rafael focus).  </li>\n<li>Care/maintenance: <strong>A$0.2m</strong>.  </li>\n<li>Corporate/admin: <strong>A$0.7m</strong>.  </li>\n</ul>\n<p><strong>Material Impact:</strong> Rafael SDA de-risks funding, divestments streamline portfolio, but tight liquidity requires near-term funding (Koloma proceeds alleviate pressure).  </p>\n<hr />\n<p><em>No material information omitted; summary tailored for trading/capital markets relevance.</em></p>",
    "usage": {
      "prompt_tokens": 7413,
      "completion_tokens": 561,
      "total_tokens": 7974,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:59:11.488457"
  },
  {
    "ticker": "RNV",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968883",
    "id": "02968883",
    "pages": 8,
    "price_sensitive": false,
    "date": "20250714",
    "time": "0848",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrrsnt7clsm1.pdf",
    "summary": "<ul>\n<li><strong>Security Issuance</strong>: 773,260 new ordinary fully paid shares (ASX: RNV) issued on 14/07/2025.  </li>\n<li><strong>Issue Type</strong>: Non-cash issuance (in lieu of services), with an estimated value of <strong>AUD 83,053</strong> total (no per-share value provided).  </li>\n<li><strong>Post-Issue Capital</strong>: Total quoted ordinary shares increase to <strong>110,220,991</strong>. Unquoted restricted securities and options remain as listed.  </li>\n<li><strong>Prior Disclosure</strong>: Part of a placement previously announced via Appendix 3B on 11-Jul-2025 (no further issues pending).  </li>\n</ul>\n<p><strong>No material trading or capital structure impacts identified beyond dilution from issuance.</strong></p>",
    "usage": {
      "prompt_tokens": 1752,
      "completion_tokens": 151,
      "total_tokens": 1903,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:58:36.787814"
  },
  {
    "ticker": "PIC",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968882",
    "id": "02968882",
    "pages": 5,
    "price_sensitive": false,
    "date": "20250714",
    "time": "0845",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrrpx020b2ly.pdf",
    "summary": "<h3><strong>Perpetual Equity Investment Co. (ASX: PIC) \u2013 Monthly NTA Report (Jun-2025)</strong></h3>\n<h4><strong>Key Metrics</strong></h4>\n<ul>\n<li><strong>NTA per share (post-tax):</strong> $1.248  </li>\n<li><strong>NTA per share (pre-tax):</strong> $1.289  </li>\n<li><strong>Trading premium/discount:</strong> -2.9% (Share price: $1.21 vs NTA $1.248)  </li>\n<li><strong>Market cap:</strong> $464M  </li>\n<li><strong>Dividend yield (grossed up):</strong> 9.4% (6.6% unfranked)  </li>\n</ul>\n<h4><strong>Portfolio Performance</strong></h4>\n<ul>\n<li><strong>1M return:</strong> +2.7% (vs ASX 300 +1.4%)  </li>\n<li><strong>1Y return:</strong> +6.5% (vs ASX 300 +13.7%) \u2013 <strong>underperformance (-7.2%)</strong>  </li>\n<li><strong>Top holdings:</strong> Flutter (7.8%), BHP (7.8%), GPT (4.5%)  </li>\n<li><strong>Key detractor:</strong> Select Harvests (-11.8%)  </li>\n</ul>\n<h4><strong>Material Updates</strong></h4>\n<ol>\n<li><strong>Flutter Entertainment (+11.1%)</strong> \u2013 Boosted by US index inclusion momentum.  </li>\n<li><strong>Aspen Group (+17.1%)</strong> \u2013 Post-capital raise optimism on housing affordability tailwinds.  </li>\n<li><strong>Cash position:</strong> 5.9% of portfolio (flexibility maintained).  </li>\n</ol>\n<h4><strong>Outlook</strong></h4>\n<ul>\n<li>Cautious on overvalued defensives, sees cyclical opportunities.  </li>\n<li>No changes announced to capital structure or corporate actions.  </li>\n</ul>\n<p><strong>Format Note:</strong> Summary excludes boilerplate, governance, and non-material commentary.</p>",
    "usage": {
      "prompt_tokens": 4025,
      "completion_tokens": 359,
      "total_tokens": 4384,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:58:51.028478"
  },
  {
    "ticker": "HSN",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968880",
    "id": "02968880",
    "pages": 2,
    "price_sensitive": true,
    "date": "20250714",
    "time": "0844",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrrkl3rdnqyj.pdf",
    "summary": "<ul>\n<li><strong>FY25 Guidance Update</strong>:  </li>\n<li><strong>Underlying EBITDA</strong> revised upward to <strong>A$110m - A$112m</strong> (previously A$92m \u2013 A$101m), expected <strong>19-21% growth</strong> vs. FY24.  </li>\n<li><strong>Cash EBITDA</strong> revised upward to <strong>A$92m - A$94m</strong> (previously A$76m \u2013 A$85m), expected <strong>20-22% growth</strong> vs. FY24.  </li>\n<li><strong>Revenue guidance adjusted downward</strong> to <strong>A$391m - A$393m</strong> (from A$398m \u2013 A$405m) due to project timing delays, but still <strong>11% growth</strong> (5% organic).  </li>\n<li>\n<p><strong>Margins</strong>: Underlying EBITDA margin ~28%; Cash EBITDA margin ~24%.  </p>\n</li>\n<li>\n<p><strong>Key Drivers</strong>: Improved efficiencies, cost discipline, and stronger-than-expected contribution from <strong>powercloud</strong> (now profitable).  </p>\n</li>\n<li>\n<p><strong>Customer Wins</strong>:  </p>\n</li>\n<li><strong>Vattenfall</strong>: A$5.5m contract (4 years).  </li>\n<li><strong>VMO2</strong>: A$50m transformative agreement (5 years).  </li>\n<li><strong>US renewables portfolio</strong>: A$16m contract (5 years).  </li>\n<li>\n<p><strong>Other wins</strong>: A$5m+ TCV, adding A$1.4m annual recurring revenue.  </p>\n</li>\n<li>\n<p><strong>Outlook</strong>: Solid pipeline; growth optimism beyond FY25.</p>\n</li>\n</ul>",
    "usage": {
      "prompt_tokens": 1380,
      "completion_tokens": 302,
      "total_tokens": 1682,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:59:35.789710"
  },
  {
    "ticker": "SYR",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968879",
    "id": "02968879",
    "pages": 4,
    "price_sensitive": false,
    "date": "20250714",
    "time": "0844",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrrhgt29jcrx.pdf",
    "summary": "<ul>\n<li><strong>Cessation of Securities</strong>: 285,731 PERFORMANCE RIGHTS (SYRAC) lapsed due to unmet conditions (ceased 07/05/2025).  </li>\n<li><strong>Issued Capital Post-Cessation</strong>:  </li>\n<li>Ordinary Shares (SYR): 1,042,244,814  </li>\n<li>Unquoted PERFORMANCE RIGHTS (SYRAC): 27,383,445  </li>\n<li>Unquoted SHARE RIGHTS (SYRAG): 3,206,815  </li>\n<li>Unquoted CONVERTIBLE NOTES (SYRAF): 3  </li>\n</ul>\n<p><em>No material trading or capital markets impact identified (routine expiry of performance rights).</em></p>",
    "usage": {
      "prompt_tokens": 1039,
      "completion_tokens": 142,
      "total_tokens": 1181,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:59:27.473576"
  },
  {
    "ticker": "OPH",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968878",
    "id": "02968878",
    "pages": 1,
    "price_sensitive": false,
    "date": "20250714",
    "time": "0843",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrrfbdy6183x.pdf",
    "summary": "<h3>Summary of ASX Announcement:</h3>\n<ul>\n<li><strong>Type</strong>: Weekly NTA Update  </li>\n<li><strong>Key Data</strong>:  </li>\n<li>NTA per Unit (Cum-distribution) as of 11/07/2025: <strong>$3.4963</strong>  </li>\n<li>Includes distribution for the year ended 30 June 2025.  </li>\n</ul>\n<p><strong>No material trading or capital markets decision triggers identified.</strong>  </p>\n<p><em>(Omitted boilerplate, disclaimers, and non-operational details.)</em></p>",
    "usage": {
      "prompt_tokens": 701,
      "completion_tokens": 100,
      "total_tokens": 801,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:59:40.888866"
  },
  {
    "ticker": "IKE",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968876",
    "id": "02968876",
    "pages": 4,
    "price_sensitive": true,
    "date": "20250714",
    "time": "0840",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrr8jflwd6d8.pdf",
    "summary": "<h3><strong>Capital Raising Announcement Summary:</strong></h3>\n<ul>\n<li><strong>Structure:</strong>  </li>\n<li><strong>Placement:</strong> Fully underwritten, raising <strong>A$18.0M</strong> (A$0.81/share).  </li>\n<li><strong>SPP:</strong> Non-underwritten, targeting <strong>A$2.0M</strong> (same price as Placement).  </li>\n<li><strong>Key Dates:</strong>  </li>\n<li><strong>Placement Settlement:</strong> 21 July 2025.  </li>\n<li><strong>Placement Trading Commences:</strong> 22 July 2025.  </li>\n<li><strong>SPP Offer Booklet Release:</strong> 16 July 2025.  </li>\n<li><strong>SPP Closing Date:</strong> 7 August 2025.  </li>\n<li><strong>Use of Proceeds:</strong>  </li>\n<li>Product development (next-gen modules for utilities/communications).  </li>\n<li>Sales/marketing acceleration.  </li>\n<li>Bolt-on acquisitions and working capital.  </li>\n<li><strong>Underwriters:</strong> Shaw and Partners, Unified Capital Partners.  </li>\n</ul>\n<p><strong>No other material information identified.</strong></p>",
    "usage": {
      "prompt_tokens": 2618,
      "completion_tokens": 203,
      "total_tokens": 2821,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:59:24.487494"
  },
  {
    "ticker": "ASK",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968875",
    "id": "02968875",
    "pages": 2,
    "price_sensitive": true,
    "date": "20250714",
    "time": "0840",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrr6f3rt8d05.pdf",
    "summary": "<p><strong>Revised Non-Binding Indicative Proposal</strong><br />\n- <strong>Revised offer</strong>: Consortium proposes <strong>A$1.65 per stapled security</strong> (cash), a <strong>~15% increase</strong> vs. initial proposal. No deduction for distributions.<br />\n- <strong>Conditions</strong>: FIRB, NZ regulatory approvals, and tax rulings remain outstanding.<br />\n- <strong>Next steps</strong>: 6-week due diligence period pending NDA/standstill agreements. <strong>No certainty</strong> binding deal will result.<br />\n- <strong>Securityholder action</strong>: <strong>No action advised</strong> at this stage.  </p>\n<p><em>Omitted: Consortium details, historical references, and adviser/contact boilerplate.</em></p>",
    "usage": {
      "prompt_tokens": 897,
      "completion_tokens": 130,
      "total_tokens": 1027,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:59:55.770026"
  },
  {
    "ticker": "VRL",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968874",
    "id": "02968874",
    "pages": 9,
    "price_sensitive": true,
    "date": "20250714",
    "time": "0839",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrr49ttb98cr.pdf",
    "summary": "<h3><strong>Material Information Summary</strong></h3>\n<ul>\n<li><strong>Resource Upgrade &amp; Expansion Drill Program Announcement</strong>  </li>\n<li><strong>Resource Upgrade Drilling</strong>:  <ul>\n<li>3,600m RC drill program commencing at Korong deposit (139koz Au inferred resource) to upgrade to Indicated JORC status.  </li>\n<li>High-grade historical intercepts include:  </li>\n<li>7m @ 13.15g/t Au  </li>\n<li>6m @ 7.24g/t Au  </li>\n<li>Mineralisation remains open in all directions, with expansion potential.  </li>\n</ul>\n</li>\n<li><strong>Project Context</strong>:  <ul>\n<li>Monument Gold Project (100% VRL) hosts 154koz Au inferred resource (3.3Mt @ 1.4g/t).  </li>\n<li>Adjacent to Genesis Minerals\u2019 (ASX: GMD) 3.3Moz Laverton Gold Project.  </li>\n<li>Over 60 untested gold targets across ~195km\u00b2 tenure.  </li>\n</ul>\n</li>\n</ul>\n<p><strong>No capital raising, financials, or trading halt details identified.</strong></p>",
    "usage": {
      "prompt_tokens": 3432,
      "completion_tokens": 213,
      "total_tokens": 3645,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T23:00:28.588800"
  },
  {
    "ticker": "MCO",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968873",
    "id": "02968873",
    "pages": 6,
    "price_sensitive": true,
    "date": "20250714",
    "time": "0838",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrr200z2d53t.pdf",
    "summary": "<h3><strong>MyEco Group Ltd (ASX: MCO) \u2013 Q4 FY25 Sales Update Summary</strong></h3>\n<h4><strong>Key Financial Highlights</strong></h4>\n<ul>\n<li><strong>FY25 Group Sales</strong>: <strong>$15.7m</strong> (\u21918.6% YoY)  </li>\n<li><strong>Q4 FY25 Sales</strong>: <strong>$4.1m</strong> (\u21914.1% YoY, \u21916.5% QoQ)  </li>\n</ul>\n<h4><strong>Segment Performance</strong></h4>\n<ul>\n<li><strong>MyEco\u00ae Global Sales</strong>: <strong>$5.3m FY25</strong> (\u219181.8% YoY)  </li>\n<li><strong>Australia retail dominance</strong>: <strong>39% market share in Coles</strong>, <strong>59% in Woolworths</strong>.  </li>\n<li><strong>USA sales</strong>: <strong>$0.1m Q4</strong> (\u219360% QoQ, impacted by US tariff policy uncertainty).  </li>\n<li><strong>White Label/Other Sales</strong>: <strong>$2.7m FY25</strong> (\u219115% YoY), driven by UK retailer <strong>Home Bargains</strong> ($0.5m initial orders).  </li>\n<li><strong>Council/Waste Management Sales</strong>: <strong>$4.7m FY25</strong> (\u21932.1% YoY), deferred <strong>$0.9m Ballarat Council</strong> revenue to FY26.  </li>\n<li><strong>Resin Sales</strong>: <strong>$2.3m FY25</strong> (\u219336.9% YoY) due to prioritization of in-house MyEco\u00ae production.  </li>\n<li><strong>Film Sales</strong>: <strong>$0.66m FY25</strong> (\u21937.6% YoY).  </li>\n</ul>\n<h4><strong>Operational &amp; Strategic Updates</strong></h4>\n<ul>\n<li><strong>Cost Savings</strong>: <strong>$2.5m FY26 fixed-cost reduction</strong> from restructuring.  </li>\n<li><strong>Market Growth Drivers</strong>:  </li>\n<li><strong>NSW Gov FOGO mandate</strong> (full rollout by 2030, commercial separation mandate from <strong>July 2026</strong>).  </li>\n<li>Focus on <strong>MyEco\u00ae branded growth</strong> over lower-margin resin/film sales.  </li>\n</ul>\n<h4><strong>Outlook</strong></h4>\n<ul>\n<li><strong>USA sales volatility</strong> due to tariff policies; 90% revenue remains non-US (mostly Australia).  </li>\n<li><strong>FY26 Council sales growth</strong> expected from FOGO adoption and NSW mandates.  </li>\n</ul>\n<p><strong>No material capital markets actions or liquidity updates identified.</strong></p>",
    "usage": {
      "prompt_tokens": 3444,
      "completion_tokens": 476,
      "total_tokens": 3920,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T23:00:37.074227"
  },
  {
    "ticker": "OPL",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968872",
    "id": "02968872",
    "pages": 3,
    "price_sensitive": false,
    "date": "20250714",
    "time": "0838",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrqzwq028f72.pdf",
    "summary": "<ul>\n<li><strong>Substantial Holder Notice</strong>: Rishi Jain Investments Pty Ltd (ACN 606 912 887) became a substantial holder in OPYL Limited (ASX: OPYL) on <strong>8 July 2025</strong>.  </li>\n<li><strong>Holdings</strong>:  </li>\n<li><strong>12,833,333 ordinary shares</strong> acquired (5.22% voting power).  </li>\n<li><strong>Acquisition details</strong>: Shares received in lieu of director fees (Dec 2024 and Jul 2025) and as a KPI bonus (833,333 shares).  </li>\n</ul>\n<p>No other material trading or capital markets impacts identified.</p>",
    "usage": {
      "prompt_tokens": 1613,
      "completion_tokens": 124,
      "total_tokens": 1737,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T23:00:59.045335"
  },
  {
    "ticker": "IMU",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968870",
    "id": "02968870",
    "pages": 6,
    "price_sensitive": true,
    "date": "20250714",
    "time": "0834",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrqtxw4h73d0.pdf",
    "summary": "<h3>Clinical Trial Update Summary:</h3>\n<ul>\n<li><strong>Phase 1b Trial Results</strong>:  </li>\n<li><strong>Response Rates</strong>: 75% ORR (9/12 patients; 6 Complete Responses, 3 Partial Responses) in relapsed/refractory DLBCL.  </li>\n<li><strong>Durability</strong>: First patient cancer-free at 15+ months; others with durable responses at 2, 5, and 11+ months.  </li>\n<li>\n<p><strong>Patient Profile</strong>: Heavily pre-treated (failed 3\u20136 prior therapies, including autologous CAR-T).  </p>\n</li>\n<li>\n<p><strong>Regulatory/Commercial Milestones</strong>:  </p>\n</li>\n<li><strong>FDA Fast Track Designation</strong>: Granted March 2025 for DLBCL.  </li>\n<li>\n<p><strong>Next Steps</strong>: Type B (End of Phase 1) meeting with FDA in Q4 2025 to discuss pivotal trial design.  </p>\n</li>\n<li>\n<p><strong>Trial Expansion</strong>: Now enrolling CAR T-na\u00efve patients in niche indications (e.g., PCNSL, CLL/SLL, MZL, WM, FL).  </p>\n</li>\n<li>\n<p><strong>Upcoming Catalyst</strong>: Additional data update expected in coming months.  </p>\n</li>\n</ul>\n<p><strong>No capital markets or liquidity-impacting information disclosed.</strong></p>",
    "usage": {
      "prompt_tokens": 2759,
      "completion_tokens": 243,
      "total_tokens": 3002,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T23:00:55.288097"
  },
  {
    "ticker": "ORI",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968871",
    "id": "02968871",
    "pages": 6,
    "price_sensitive": false,
    "date": "20250714",
    "time": "0834",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrqx3bmp5kyz.pdf",
    "summary": "<ul>\n<li><strong>Buy-back Type</strong>: On-market buy-back  </li>\n<li><strong>Total Buy-back Limit</strong>: Up to $400 million AUD worth of ordinary shares  </li>\n<li><strong>Start Date</strong>: 28/3/2025  </li>\n<li><strong>End Date</strong>: 27/3/2026  </li>\n<li><strong>Securities Bought Back (as of 11/7/2025)</strong>: 8,567,464 (cumulative) + 162,310 (previous day)  </li>\n<li><strong>Total Consideration Paid</strong>: AUD 161,137,448.94 (cumulative) + AUD 3,304,258.29 (previous day)  </li>\n<li><strong>Price Range</strong>: AUD 16.95 (low) to AUD 20.55 (high)  </li>\n<li><strong>Broker</strong>: Goldman Sachs Australia Pty Ltd  </li>\n<li><strong>Condition</strong>: Buy-back may vary/suspend/terminate depending on market conditions.  </li>\n</ul>\n<p>No material changes or additional impacts identified.</p>",
    "usage": {
      "prompt_tokens": 1578,
      "completion_tokens": 192,
      "total_tokens": 1770,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:59:16.860955"
  },
  {
    "ticker": "RG8",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968869",
    "id": "02968869",
    "pages": 1,
    "price_sensitive": false,
    "date": "20250714",
    "time": "0833",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrqrpsn8t59z.pdf",
    "summary": "<ul>\n<li><strong>Weekly NTA Update</strong>: Estimated NTA per share as of 11 July 2025 was <strong>$2.36</strong> (post-tax, unaudited).  </li>\n<li><em>No other material information identified</em>.  </li>\n</ul>\n<p><em>Note: This is a routine weekly NTA disclosure; no structural, liquidity, or capital-related updates provided.</em></p>",
    "usage": {
      "prompt_tokens": 710,
      "completion_tokens": 69,
      "total_tokens": 779,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:58:17.555785"
  },
  {
    "ticker": "OPL",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968868",
    "id": "02968868",
    "pages": 4,
    "price_sensitive": false,
    "date": "20250714",
    "time": "0833",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrqpn2nwrjyp.pdf",
    "summary": "<h3><strong>Material Information Summary</strong></h3>\n<p><strong>Director Interest Changes (Appendix 3Y)</strong><br />\n- <strong>Damon Rasheed (Indirect Interest via ITE Marketing and Investments Pty Ltd):</strong><br />\n  - <strong>Acquired:</strong> 4,500,000 ordinary shares + 2,250,000 unlisted options ($0.03 expiring 17/12/2027).<br />\n  - <strong>Consideration:</strong> In lieu of executive director salary (1 Jan 2025 \u2013 30 Jun 2025).  </p>\n<ul>\n<li><strong>Saurabh Jain (Indirect Interest via Rishi Jain Investments/Smnaa Investments):</strong>  </li>\n<li><strong>Acquired:</strong> 12,000,000 ordinary shares + 6,000,000 unlisted options ($0.03 expiring 17/12/2027).  </li>\n<li><strong>Transferred (off-market):</strong> 6,000,000 ordinary shares from Smnaa Investments to Rishi Jain Investments (no consideration).  </li>\n<li><strong>Consideration:</strong> Shares/options issued in lieu of director salary (same period as above).  </li>\n</ul>\n<p><strong>Impact:</strong> Significant increase in directors' equity-linked compensation, potentially dilutive if options are exercised. No closed-period trading concerns.  </p>\n<p><strong>No other material information identified.</strong></p>",
    "usage": {
      "prompt_tokens": 2587,
      "completion_tokens": 258,
      "total_tokens": 2845,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:58:14.605652"
  },
  {
    "ticker": "S32",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968867",
    "id": "02968867",
    "pages": 2,
    "price_sensitive": true,
    "date": "20250714",
    "time": "0833",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrqmhpdz9v67.pdf",
    "summary": "<ul>\n<li><strong>Mozal Aluminium electricity supply uncertainty</strong>: Current agreement expires March 2026; negotiations for affordable tariff unsuccessful amid drought-related hydro-power disruptions.  </li>\n<li><strong>Impairment expected</strong>: FY25 results to include impairment expense due to uncertain future electricity supply; quantum not yet disclosed.  </li>\n<li><strong>FY26 production guidance under review</strong>: Pending resolution of supply negotiations.  </li>\n</ul>\n<p><em>No capital markets action required; monitor for impairment amount and supply updates.</em></p>",
    "usage": {
      "prompt_tokens": 1116,
      "completion_tokens": 92,
      "total_tokens": 1208,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:59:47.260235"
  },
  {
    "ticker": "POL",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968866",
    "id": "02968866",
    "pages": 2,
    "price_sensitive": true,
    "date": "20250714",
    "time": "0832",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrqkfg4kl1fv.pdf",
    "summary": "<ul>\n<li><strong>Capital Raising Announcement</strong>:  </li>\n<li><strong>Structure</strong>: Placement  </li>\n<li><strong>Total Raised</strong>: AUD $15 million (net proceeds $14.97 million).  </li>\n<li><strong>Issue Price</strong>: $0.80 per share.  </li>\n<li><strong>Shares Issued</strong>: 18,750,000 new shares.  </li>\n<li><strong>Total Shares on Issue Post-Placement</strong>: 267,813,677.  </li>\n<li><strong>Use of Proceeds</strong>: Replace undrawn US$10 million debt facility for working capital during Endeavor Mine ramp-up.  </li>\n<li><strong>Trading Date for New Shares</strong>: 14 July 2025.  </li>\n</ul>\n<p>No other material information identified.</p>",
    "usage": {
      "prompt_tokens": 1348,
      "completion_tokens": 140,
      "total_tokens": 1488,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:59:52.575958"
  },
  {
    "ticker": "EMS",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968864",
    "id": "02968864",
    "pages": 1,
    "price_sensitive": false,
    "date": "20250714",
    "time": "0831",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrqdz89j8lgl.pdf",
    "summary": "<h3>Summary of ASX Announcement (EMS - Eastern Metals Limited)</h3>\n<p><strong>Announcement Type:</strong> Proposed Acquisition &amp; Capital Raising Update  </p>\n<h4><strong>Key Material Information:</strong></h4>\n<ul>\n<li><strong>Revised Transaction Structure:</strong> EMS is now considering a <strong>takeover bid or scheme of arrangement</strong> to acquire 100% of Raptor Resources Limited (RRL), due to RRL's status as a public company with &gt;50 shareholders.  </li>\n<li><strong>Capital Raising Details:</strong>  </li>\n<li><strong>Type:</strong> Placement to sophisticated/professional investors.  </li>\n<li><strong>Amount:</strong> <strong>A$4M\u2013A$5M</strong> (before costs).  </li>\n<li><strong>Price:</strong> <strong>A$0.02 per share</strong>.  </li>\n<li><strong>Exclusivity Deadline:</strong> Binding exclusivity with RRL expires <strong>15 July 2025</strong> (subject to extension).  </li>\n<li><strong>Status:</strong> Transaction remains <strong>non-binding</strong>; no certainty of completion.  </li>\n</ul>\n<p><strong>Omitted:</strong> Background, director details, legal boilerplate.</p>",
    "usage": {
      "prompt_tokens": 733,
      "completion_tokens": 201,
      "total_tokens": 934,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:58:42.645757"
  },
  {
    "ticker": "VBX",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968862",
    "id": "02968862",
    "pages": 12,
    "price_sensitive": true,
    "date": "20250714",
    "time": "0829",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrq8jmjzrv76.pdf",
    "summary": "<p>Here\u2019s the concise extraction of material information for trading/capital markets decisions:  </p>\n<p><strong>Quarterly Activities Report (Key Highlights)</strong><br />\n- <strong>Capital Raising (IPO)</strong>: Successfully completed oversubscribed IPO, raising <strong>$10m</strong> (16.7m shares at $0.60/share).<br />\n- <strong>Financials</strong>: <strong>$9.5m cash, no debt</strong> (as of 30 June 2025).<br />\n- <strong>Wuudagu Project (PFS Results)</strong>:<br />\n  - Pre-tax <strong>NPV8: $821m</strong>, <strong>IRR: 136%</strong>, <strong>EBITDA: $143m/yr</strong>.<br />\n  - <strong>First-quartile cost position</strong> (AISC: $54/t) due to high-grade, low-silica bauxite (45.4% Al\u2082O\u2083, 3.6% SiO\u2082).<br />\n  - <strong>59Mt Probable Reserve</strong> over 10-year mine life; <strong>96Mt Indicated/Inferred Resource</strong> (52% plateau area undrilled).<br />\n- <strong>Market</strong>: Strong Chinese bauxite demand (78% reliant on Guinea, facing supply risks). Wuudagu product priced comparably to premium Guinean bauxite (~US$75/t).<br />\n- <strong>Upcoming Catalysts</strong>: DFS completion (Q4 2025), project financing (Q2 2026), first production (Q4 2026).  </p>\n<p><strong>Omitted</strong>: Non-material operational details, director commentary, legal boilerplate.  </p>\n<p><em>No material information omitted; all key financial, project, and market data included.</em></p>",
    "usage": {
      "prompt_tokens": 7363,
      "completion_tokens": 332,
      "total_tokens": 7695,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T23:00:20.389277"
  },
  {
    "ticker": "OCC",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968863",
    "id": "02968863",
    "pages": 5,
    "price_sensitive": false,
    "date": "20250714",
    "time": "0829",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrqbmy0j58fr.pdf",
    "summary": "<ul>\n<li><strong>Type:</strong> Appendix 3H \u2013 Notification of cessation of securities  </li>\n<li><strong>Entity:</strong> Orthocell Limited (ASX: OCC)  </li>\n<li><strong>Details:</strong>  </li>\n<li><strong>Securities Ceased:</strong> 250,000 unquoted options (OCCAV) expired on 13/07/2025 at exercise price $0.403 (no exercise/conversion).  </li>\n<li><strong>Post-Cessation Capital Structure:</strong>  <ul>\n<li><strong>Quoted:</strong> 244,800,004 ordinary shares (OCC).  </li>\n<li><strong>Unquoted:</strong> Multiple tranches of options/rights (see Part 3.2 for full list).  </li>\n</ul>\n</li>\n</ul>\n<p><strong>No material trading or capital markets impact identified</strong> (routine expiry of out-of-the-money options).</p>",
    "usage": {
      "prompt_tokens": 1499,
      "completion_tokens": 158,
      "total_tokens": 1657,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T23:00:41.266913"
  },
  {
    "ticker": "VG1",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968861",
    "id": "02968861",
    "pages": 1,
    "price_sensitive": false,
    "date": "20250714",
    "time": "0828",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrq64p0xxn8d.pdf",
    "summary": "<ul>\n<li><strong>Weekly NTA Update (14 July 2025)</strong>: Estimated NTA per share as of 11 July 2025: <strong>$2.06</strong> (post-tax, inclusive of fees and charges).  </li>\n</ul>\n<p><em>No other material information identified.</em></p>",
    "usage": {
      "prompt_tokens": 622,
      "completion_tokens": 53,
      "total_tokens": 675,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:54:20.332139"
  },
  {
    "ticker": "RMS",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968858",
    "id": "02968858",
    "pages": 3,
    "price_sensitive": true,
    "date": "20250714",
    "time": "0827",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrpzrkyls2pl.pdf",
    "summary": "<ul>\n<li><strong>Scheme Approval</strong>: Spartan shareholders approved the proposed acquisition by Ramelius Resources with 90.3% of eligible shareholders and 96.3% of votes cast in favour.  </li>\n<li><strong>Transaction Terms</strong>: $0.25 cash + 0.6957 Ramelius shares per Spartan share.  </li>\n<li><strong>Key Dates</strong>:  </li>\n<li>Court hearing for final approval: <strong>21 July 2025</strong>.  </li>\n<li>Last trading day (if approved): <strong>22 July 2025</strong>.  </li>\n<li>Scheme record date: <strong>24 July 2025</strong> (5pm AWST).  </li>\n<li>Implementation date: <strong>31 July 2025</strong>.  </li>\n<li><strong>Next Steps</strong>: ASX suspension expected post-court approval (from close of trading on 22 July 2025).</li>\n</ul>",
    "usage": {
      "prompt_tokens": 1796,
      "completion_tokens": 160,
      "total_tokens": 1956,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:53:44.032927"
  },
  {
    "ticker": "AXE",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968859",
    "id": "02968859",
    "pages": 9,
    "price_sensitive": true,
    "date": "20250714",
    "time": "0827",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrq1tt9h7cqw.pdf",
    "summary": "<h3><strong>Quarterly Report (Appendix 4C) Summary</strong></h3>\n<h4><strong>Key Highlights</strong></h4>\n<ul>\n<li><strong>Quantum Computing (12CQ Project):</strong> Extended collaboration with Queen Mary University of London (QMUL) to advance qubit development, targeting a demonstration by <strong>1HCY26</strong>.  </li>\n<li><strong>Biochip Development:</strong>  </li>\n<li>Partnered with <strong>Paragraf</strong> to improve graphene-based sensor (gFET) accuracy for blood testing.  </li>\n<li>Fabricated <strong>integrated silicon chip</strong> (combining gFET with readout circuitry), a step toward a handheld diagnostic device.  </li>\n<li><strong>Advisory Committee:</strong> Formed a high-profile advisory team (Dr. Steven Duvall, Mark Davis, Dr. Anthony Brewer) to guide commercialization.  </li>\n<li><strong>Financials:</strong>  </li>\n<li><strong>Cash balance:</strong> <strong>$13.7 million</strong> (no debt).  </li>\n<li><strong>Investments:</strong> Holds shares in <strong>Volatus Capital (CSE:VC)</strong> and <strong>ChemX Materials (ASX:CMX)</strong>.  </li>\n<li>Quarterly <strong>operating cash outflow: ($1.8M)</strong>; estimated funding runway: <strong>7.7 quarters</strong>.  </li>\n</ul>\n<h4><strong>Material Developments</strong></h4>\n<ul>\n<li><strong>Intellectual Property (IP):</strong> Archer retains all IP from collaborations (QMUL, Paragraf).  </li>\n<li><strong>Milestone Targets:</strong> Focus on <strong>qubit demonstration (2026)</strong> and <strong>Biochip lab-to-production transition</strong>.  </li>\n</ul>\n<p><strong>Omitted:</strong> Routine operational details, director bios, legal disclaimers.  </p>\n<p><strong>Final Note:</strong> No capital raising, M&amp;A, or material governance changes announced. Focus remains on R&amp;D progress and cash runway.</p>",
    "usage": {
      "prompt_tokens": 5162,
      "completion_tokens": 341,
      "total_tokens": 5503,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:55:18.519676"
  },
  {
    "ticker": "FPR",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968860",
    "id": "02968860",
    "pages": 6,
    "price_sensitive": false,
    "date": "20250714",
    "time": "0827",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrq3xkz0nznr.pdf",
    "summary": "<ul>\n<li><strong>Buy-back Type</strong>: On-market buy-back  </li>\n<li><strong>Total Shares Bought Back (Cumulative)</strong>: 79,465,974  </li>\n<li><strong>Shares Bought Back (Previous Day)</strong>: 92,000  </li>\n<li><strong>Total Consideration Paid (Cumulative)</strong>: AUD 211,014,813.73  </li>\n<li><strong>Consideration Paid (Previous Day)</strong>: AUD 294,050.40  </li>\n<li><strong>Buy-back Period</strong>: 10 May 2023 to 23 January 2026  </li>\n<li><strong>Maximum Buy-back Cap</strong>: 25 million shares approved at AGM (23 January 2025)  </li>\n<li><strong>Broker</strong>: Morgan Stanley Australia Securities Limited  </li>\n<li><strong>No Shareholder Approval Required</strong>  </li>\n</ul>\n<p><em>No other material information identified.</em></p>",
    "usage": {
      "prompt_tokens": 1547,
      "completion_tokens": 158,
      "total_tokens": 1705,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:54:11.673112"
  },
  {
    "ticker": "ATG",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968857",
    "id": "02968857",
    "pages": 26,
    "price_sensitive": false,
    "date": "20250714",
    "time": "0826",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrpxk2hh08cj.pdf",
    "summary": "<h3><strong>Material Information Summary</strong></h3>\n<h4><strong>Type: Board Dispute &amp; EGM Notice</strong></h4>\n<ul>\n<li><strong>EGM Details</strong>: Scheduled for <strong>22 August 2025</strong> to vote on replacing the entire board with four new candidates (Richard Cawsey, Andrew Nash, Carole Campbell, Christine Christian).  </li>\n<li><strong>Board Opposition</strong>: Current board unanimously recommends <strong>against all resolutions</strong>, citing:  </li>\n<li>Risk of disrupting ongoing turnaround strategy (e.g., improved margins, cost savings).  </li>\n<li>Proposed board lacks global expertise (90% of revenue is international).  </li>\n<li><strong>Strategic Progress</strong>:  </li>\n<li><strong>1H FY25 gross margin</strong> up <strong>220 bps</strong> YoY; FY25 guidance reaffirmed (11 June 2025).  </li>\n<li>Strategic review underway for <strong>capital structure optimization</strong> and portfolio positioning.  </li>\n</ul>\n<h4><strong>Key Dates</strong></h4>\n<ul>\n<li><strong>Record Date</strong>: <strong>20 August 2025</strong> (for voting eligibility).  </li>\n<li><strong>Results Date</strong>: FY25 financials to be released <strong>14 August 2025</strong> (pre-EGM).  </li>\n</ul>\n<h4><strong>Voting Instructions</strong></h4>\n<ul>\n<li>Shareholders encouraged to vote <strong>online/by proxy</strong> by <strong>20 August 2025</strong>.  </li>\n</ul>\n<p><em>No capital raising or trading halt requested.</em></p>",
    "usage": {
      "prompt_tokens": 12467,
      "completion_tokens": 256,
      "total_tokens": 12723,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:55:38.900368"
  },
  {
    "ticker": "NDO",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968854",
    "id": "02968854",
    "pages": 6,
    "price_sensitive": false,
    "date": "20250714",
    "time": "0825",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrpq5gf21m2q.pdf",
    "summary": "<ul>\n<li><strong>Buy-back Type:</strong> On-market buy-back  </li>\n<li><strong>Securities Bought Back (Previous Day):</strong> 29,850 NDO ordinary shares  </li>\n<li><strong>Consideration Paid (Previous Day):</strong> AUD 19,999.50  </li>\n<li><strong>Price Range (Previous Day):</strong> AUD 0.670 (flat)  </li>\n<li><strong>Remaining Buy-back Capacity:</strong> 21,856,557 shares (out of 22,566,736 maximum)  </li>\n<li><strong>Buy-back Period:</strong> 14/3/2025 to 13/3/2026</li>\n</ul>",
    "usage": {
      "prompt_tokens": 1499,
      "completion_tokens": 117,
      "total_tokens": 1616,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:48:29.318096"
  },
  {
    "ticker": "OSX",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968852",
    "id": "02968852",
    "pages": 3,
    "price_sensitive": true,
    "date": "20250714",
    "time": "0825",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrpl0gdz4qpr.pdf",
    "summary": "<ul>\n<li><strong>Regulatory Approval</strong>: Osteopore (ASX: OSX) secures Swiss market approval under EU Medical Device Regulation (MDR) for its off-the-shelf and custom-made implants.  </li>\n<li><strong>Strategic Impact</strong>: Completes product portfolio for European market entry, bolstered by existing partnership with Zimmer Biomet (distribution in EMEA, APAC, Australia, NZ).  </li>\n<li><strong>Market Opportunity</strong>: European cranial implant market projected to reach <strong>USD527.6 million by 2027</strong>, with custom implants as the largest segment.  </li>\n</ul>\n<p><strong>No trading or capital-raising details identified.</strong>  </p>\n<p><em>(Note: Excluded forward-looking statements, operational background, and CEO commentary as non-material to immediate trading decisions.)</em></p>",
    "usage": {
      "prompt_tokens": 1567,
      "completion_tokens": 146,
      "total_tokens": 1713,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:47:54.511569"
  },
  {
    "ticker": "DNL",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968853",
    "id": "02968853",
    "pages": 6,
    "price_sensitive": false,
    "date": "20250714",
    "time": "0825",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrpn2p6b53pq.pdf",
    "summary": "<ul>\n<li><strong>Type of Buy-back</strong>: On-market buy-back  </li>\n<li><strong>Total Shares Bought Back (as of previous day)</strong>: 111,848,671 shares (cumulative) + 578,704 shares (previous day)  </li>\n<li><strong>Buy-back Program Details</strong>:  </li>\n<li><strong>Total Program Size</strong>: Up to AUD $400 million (no fixed share target)  </li>\n<li><strong>Buy-back Period</strong>: 13/5/2025 to 28/11/2025  </li>\n<li><strong>Previous Day Activity</strong>:  </li>\n<li><strong>Consideration Paid</strong>: AUD 1,642,072.60  </li>\n<li><strong>Price Range</strong>: AUD 2.82000 (low) to AUD 2.86000 (high)  </li>\n<li><strong>Total Consideration Paid (cumulative)</strong>: AUD 326,259,504.90  </li>\n<li><strong>No shareholder approval required</strong>.  </li>\n</ul>\n<p><strong>Key Takeaway</strong>: Ongoing on-market buy-back with significant cumulative repurchases (111.8M shares for AUD 326.3M), active daily trading, and a remaining capacity under the AUD 400M program.</p>",
    "usage": {
      "prompt_tokens": 1579,
      "completion_tokens": 225,
      "total_tokens": 1804,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:46:50.841363"
  },
  {
    "ticker": "VG1",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968856",
    "id": "02968856",
    "pages": 6,
    "price_sensitive": false,
    "date": "20250714",
    "time": "0825",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrpvd2rbd2vw.pdf",
    "summary": "<ul>\n<li><strong>Buy-back type</strong>: On-market  </li>\n<li><strong>Total securities bought back as of 11/7/2025</strong>: 14,608,249  </li>\n<li><strong>Securities bought back on 11/7/2025</strong>: 9,626  </li>\n<li><strong>Maximum buy-back target</strong>: 67,382,076 remaining (52,764,201 left as of 11/7/2025)  </li>\n<li><strong>Price range (previous day)</strong>: AUD 1.755 (low) to AUD 1.765 (high)  </li>\n<li><strong>Buy-back period</strong>: Estimated 26/11/2024 to 24/11/2025  </li>\n<li><strong>Broker</strong>: Third Party Platform Pty Ltd  </li>\n</ul>\n<p><em>No material deviations or new approvals noted.</em></p>",
    "usage": {
      "prompt_tokens": 1568,
      "completion_tokens": 155,
      "total_tokens": 1723,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:46:09.299689"
  },
  {
    "ticker": "CWY",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968851",
    "id": "02968851",
    "pages": 3,
    "price_sensitive": false,
    "date": "20250714",
    "time": "0824",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrphxnwh3r7t.pdf",
    "summary": "<p><strong>Form 604 \u2013 Change in Substantial Holding (Cleanaway Waste Management Ltd.)</strong>  </p>\n<ul>\n<li><strong>Substantial Holder:</strong> The Capital Group Companies, Inc. (via Capital Research and Management Company).  </li>\n<li><strong>Change in Holding:</strong> Increased stake from <strong>5.25% (117,217,544 shares)</strong> to <strong>6.31% (140,839,294 shares)</strong>.  </li>\n<li><strong>Key Transactions (Annexure A):</strong>  </li>\n<li>Largest single acquisition: <strong>7,000,000 shares</strong> (AUD 19.25M) on <strong>19-Jun-2025</strong>.  </li>\n<li>Recent purchases (10-Jul-2025): <strong>1,393,088 shares</strong> (AUD 3.94M).  </li>\n<li>Total estimated consideration (all transactions): <strong>~AUD 56.76M</strong> (calculated from listed amounts).  </li>\n</ul>\n<p><strong>Material Implication:</strong> Significant institutional accumulation (+1.06% stake), signaling bullish outlook. Monitor for further buying activity.</p>",
    "usage": {
      "prompt_tokens": 2034,
      "completion_tokens": 206,
      "total_tokens": 2240,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:36:14.112989"
  },
  {
    "ticker": "BMM",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968847",
    "id": "02968847",
    "pages": 7,
    "price_sensitive": true,
    "date": "20250714",
    "time": "0824",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrp7k1dzs234.pdf",
    "summary": "<h3>Material Information Summary:</h3>\n<ul>\n<li><strong>New Strategic Claims Staked</strong>: Bayan has applied for 45 new lode claims (\"Desert Star North Project\"), expanding its landholding to <strong>117 claims</strong> (~3.75 km\u00b2) in a rare earth/gold corridor.  </li>\n<li><strong>Proximity to Major Deposits</strong>: Claims are <strong>3 km north</strong> of Colosseum Gold Mine (JORC Resource: <strong>27.1 Mt @ 1.26 g/t Au</strong>) and near Mountain Pass Rare Earth Mine.  </li>\n<li><strong>Exploration Plan</strong>: Reconnaissance mapping and geochemical sampling to commence <strong>in coming weeks</strong>; targeting REE/gold mineralization.  </li>\n<li><strong>Key Risk</strong>: BLM claim grants pending\u2014final tenure status to be confirmed.  </li>\n</ul>\n<p><em>No capital raising, financials, or trading halt details identified.</em></p>",
    "usage": {
      "prompt_tokens": 3151,
      "completion_tokens": 172,
      "total_tokens": 3323,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:35:57.023635"
  },
  {
    "ticker": "I88",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968849",
    "id": "02968849",
    "pages": 5,
    "price_sensitive": true,
    "date": "20250714",
    "time": "0824",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrpcr40jrzlm.pdf",
    "summary": "<h3>Summary of ASX Announcement \u2013 Infini Resources (ASX: I88)</h3>\n<p><strong>Announcement Type: Exploration Update</strong>  </p>\n<ul>\n<li><strong>Project:</strong> Portland Creek Uranium Project (100%-owned).  </li>\n<li><strong>Key Findings:</strong>  </li>\n<li><strong>Uranium-in-soil anomalies</strong> up to <strong>74,997 ppm U\u2083O\u2088 (~7.5%)</strong> over a <strong>6km corridor</strong>, with primary structures untested in Phase 1 drilling.  </li>\n<li><strong>New structural/uranium experts engaged</strong> (Newexco, Mark Couzens) to refine exploration model for <strong>Phase 2 drilling</strong> (Q3 2025).  </li>\n<li>\n<p><strong>Potential for large-scale uranium deposit</strong> inferred from high-grade soils, hydrothermal alteration, and pathfinder elements.  </p>\n</li>\n<li>\n<p><strong>Next Steps:</strong>  </p>\n</li>\n<li>Phase 2 diamond drilling planned for <strong>Q3 2025</strong>, targeting shear-hosted or alternative uranium styles.  </li>\n</ul>\n<p><strong>No capital, financial, or trading halt information disclosed.</strong>  </p>\n<p><em>Brevity note: Excluded operational/background details (e.g., historic resources, project location) as they do not materially impact near-term valuation or liquidity.</em></p>",
    "usage": {
      "prompt_tokens": 3254,
      "completion_tokens": 243,
      "total_tokens": 3497,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:32:46.657054"
  },
  {
    "ticker": "GUM",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968846",
    "id": "02968846",
    "pages": 3,
    "price_sensitive": false,
    "date": "20250714",
    "time": "0824",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrp5gstrb8hd.pdf",
    "summary": "<h3>Summary (Appendix 3Y - Change of Director\u2019s Interest Notice):</h3>\n<ul>\n<li><strong>Director</strong>: Geoff Stalley  </li>\n<li><strong>Change Type</strong>: Indirect on-market purchase of shares via Finclear Services Pty Ltd (Superhero Securities A/C).  </li>\n<li><strong>Securities</strong>: 5,500 fully paid ordinary shares acquired at <strong>$0.095 per share</strong>.  </li>\n<li><strong>Holding Post-Change</strong>: 55,500 shares (previously 50,000).  </li>\n<li><strong>Additional Note</strong>: Late filing due to administrative oversight; deemed isolated.  </li>\n</ul>\n<p>No material impact on valuation, liquidity, or capital structure identified.</p>",
    "usage": {
      "prompt_tokens": 1173,
      "completion_tokens": 128,
      "total_tokens": 1301,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:33:44.688883"
  },
  {
    "ticker": "VTM",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968848",
    "id": "02968848",
    "pages": 2,
    "price_sensitive": false,
    "date": "20250714",
    "time": "0824",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrp9msys51bh.pdf",
    "summary": "<h3><strong>Material Information Summary</strong></h3>\n<ul>\n<li><strong>U.S. Federal Approval Secured</strong>: Victory Metals (ASX: VTM) receives SAM.gov approval, allowing direct engagement with the U.S. Department of Defense (DoD) and access to federal programs (e.g., Defense Production Act, EXIM Bank funding).  </li>\n<li><strong>Key Implications</strong>:  </li>\n<li>Eligibility for strategic procurement, federal funding (including previously announced US$190M LOI from EXIM Bank).  </li>\n<li>Strengthened credibility for global offtake agreements, particularly with U.S., Japanese, and European partners.  </li>\n<li>Validation as a secure, non-Chinese critical minerals supplier (heavy rare earths, Scandium, Hafnium, Gallium).  </li>\n<li><strong>Project Highlight</strong>: North Stanmore (WA) is a major heavy rare earths deposit with low radioactivity and high-value elements (Dysprosium, Terbium).  </li>\n</ul>\n<p><em>No financial/trading actions or capital structure impacts identified.</em>  </p>\n<p><em>(Omitted: CEO quote, operational details, non-material project specifics.)</em></p>",
    "usage": {
      "prompt_tokens": 1161,
      "completion_tokens": 219,
      "total_tokens": 1380,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:32:38.596776"
  },
  {
    "ticker": "ETM",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968850",
    "id": "02968850",
    "pages": 2,
    "price_sensitive": true,
    "date": "20250714",
    "time": "0824",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrpftwrbnhny.pdf",
    "summary": "<h3>Summary of ASX Announcement:</h3>\n<ul>\n<li><strong>Potential Acquisition</strong>: ETM's subsidiary (ETM Spain) submitted a <strong>binding offer of \u20ac3.6M (~A$6.4M)</strong> to acquire the Penouta Mine (Spain), a tin-tantalum-niobium asset.  </li>\n<li><strong>Key Conditions</strong>: Offer subject to being selected as preferred bidder, regulatory approvals, and execution of sale deed. <strong>\u20ac500K deposit paid</strong> (refundable if unsuccessful).  </li>\n<li><strong>Strategic Rationale</strong>: Penouta is Europe\u2019s sole tantalum-niobium mine, aligning with ETM\u2019s diversification strategy.  </li>\n<li><strong>Uncertainty</strong>: No assurance of successful bid; competing offers may still emerge. Expected completion by <strong>end-2025</strong> if approved.  </li>\n<li><strong>Funding</strong>: To be funded from existing cash reserves.  </li>\n</ul>\n<p><strong>Material Impact</strong>: Potential expansion into critical minerals, but high execution risk due to competitive bid process and approvals.  </p>\n<p><em>Omitted: Background on other projects, director contacts, legal boilerplate.</em></p>",
    "usage": {
      "prompt_tokens": 1291,
      "completion_tokens": 217,
      "total_tokens": 1508,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:34:48.296191"
  },
  {
    "ticker": "POL",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968842",
    "id": "02968842",
    "pages": 1,
    "price_sensitive": false,
    "date": "20250714",
    "time": "0823",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrnx4s05ky9p.pdf",
    "summary": "<ul>\n<li><strong>Capital Raising Announcement</strong>: Placement of 18,750,000 shares to exempt investors under Section 708A of Corporations Act.  </li>\n<li><strong>No other material information identified</strong> (cleansing notice only confirms regulatory compliance).  </li>\n</ul>\n<p><em>Note: No details on capital raised (AUD), pricing, or use of proceeds provided in this notice.</em></p>",
    "usage": {
      "prompt_tokens": 550,
      "completion_tokens": 72,
      "total_tokens": 622,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:34:18.756184"
  },
  {
    "ticker": "JLL",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968845",
    "id": "02968845",
    "pages": 2,
    "price_sensitive": false,
    "date": "20250714",
    "time": "0823",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrp3d195drz2.pdf",
    "summary": "<p><strong>Summary of ASX Announcement</strong>  </p>\n<ul>\n<li><strong>Appointment of Key Executive</strong>: Matt Haas appointed as Vice President \u2013 Studies and Development to lead US operations for the McDermitt Lithium Project.  </li>\n<li><strong>Project Advancement</strong>: Role focused on advancing technical studies (mining, processing, infrastructure) for McDermitt, a major US lithium asset.  </li>\n</ul>\n<p><em>No material trading or capital markets impact identified</em> (Executive appointment only, no financial/capital structure changes disclosed).</p>",
    "usage": {
      "prompt_tokens": 1439,
      "completion_tokens": 95,
      "total_tokens": 1534,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:32:49.608193"
  },
  {
    "ticker": "LSF",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968844",
    "id": "02968844",
    "pages": 1,
    "price_sensitive": false,
    "date": "20250714",
    "time": "0823",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrp1bb0p2v2v.pdf",
    "summary": "<ul>\n<li><strong>NTA per Share (pre-tax) as of 09 July 2025</strong>: $3.3330  </li>\n<li><strong>NTA per Share (post-tax) as of 09 July 2025</strong>: $3.1782  </li>\n</ul>\n<p>(Note: No material trading or capital markets decisions identified beyond NTA update.)</p>",
    "usage": {
      "prompt_tokens": 440,
      "completion_tokens": 67,
      "total_tokens": 507,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:34:12.857635"
  },
  {
    "ticker": "AOK",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968843",
    "id": "02968843",
    "pages": 5,
    "price_sensitive": false,
    "date": "20250714",
    "time": "0823",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrnz70d62pw9.pdf",
    "summary": "<p><strong>Operational Business Update Summary:</strong>  </p>\n<ul>\n<li><strong>Reclamation Board Wells (Rec Board-7 &amp; -8):</strong>  </li>\n<li>Currently flowing unassisted at <strong>215 mscf/d</strong> (peak 275 mscf/d).  </li>\n<li>\n<p>Plan to install smaller compressors to boost flows further.  </p>\n</li>\n<li>\n<p><strong>Borba Well (Californian leases):</strong>  </p>\n</li>\n<li><strong>Uneconomic</strong> due to small gas pool (0.5\u20131.5 Bcf), high nitrogen content, and lack of pipeline access.  </li>\n<li>\n<p>Leases expired; asset deemed immaterial.  </p>\n</li>\n<li>\n<p><strong>Dempsey Well:</strong>  </p>\n</li>\n<li>Shut in due to integrity issues; reviewing remediation potential.  </li>\n<li>\n<p>Lease not material; may be relinquished.  </p>\n</li>\n<li>\n<p><strong>Other Leases:</strong>  </p>\n</li>\n<li><strong>Malton, Los Medanos, Dutch Slough:</strong> Shut-in royalties paid; assessing tie-in/redevelopment.  </li>\n<li>\n<p><strong>Rio Vista:</strong> Producing (Rec Board-7 &amp; -8; 100% WI).  </p>\n</li>\n<li>\n<p><strong>New Ventures:</strong>  </p>\n</li>\n<li>Evaluating opportunities in Africa, South America, and Australasia amid energy security trends.  </li>\n<li>Strengthened balance sheet post-recent settlement (3 July 2025).  </li>\n</ul>\n<p><strong>No material financial data (e.g., cash balance) or capital markets activity disclosed.</strong></p>",
    "usage": {
      "prompt_tokens": 3124,
      "completion_tokens": 277,
      "total_tokens": 3401,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:33:41.567138"
  },
  {
    "ticker": "MAQ",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968840",
    "id": "02968840",
    "pages": 2,
    "price_sensitive": true,
    "date": "20250714",
    "time": "0823",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrns09fcgryz.pdf",
    "summary": "<h3>Summary of Material Information:</h3>\n<ul>\n<li><strong>Land Acquisition for Data Centre Campus</strong> \u2013 MAQ subsidiary enters put/call option to acquire Sydney land for new data centre campus (targeting &gt;150MW IT load).  </li>\n<li><strong>Purchase Price</strong> \u2013 $240M (to be funded via cash reserves and corporate debt facility).  </li>\n<li><strong>Timetable</strong> \u2013 Subdivision approval required (expected to take months); exercise window post-approval.  </li>\n<li><strong>Strategic Impact</strong> \u2013 Expands pipeline for hyperscale/AI/govt workloads; aligns with long-term capacity strategy (7\u201310 years).  </li>\n<li><strong>Funding Note</strong> \u2013 Future stages may involve project finance or infrastructure investors.  </li>\n<li><strong>IC3 SuperWest Update</strong> \u2013 Phase 1 on track (Sept 2026 completion); Phases 2\u20134 to follow demand.  </li>\n</ul>\n<p><em>No material financial/operational KPIs or immediate trading impacts disclosed.</em></p>",
    "usage": {
      "prompt_tokens": 987,
      "completion_tokens": 188,
      "total_tokens": 1175,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:33:13.885422"
  },
  {
    "ticker": "KRR",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968841",
    "id": "02968841",
    "pages": 24,
    "price_sensitive": true,
    "date": "20250714",
    "time": "0823",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrnv23p1mjdq.pdf",
    "summary": "<p>Here\u2019s a concise summary of the material information from the ASX announcement by <strong>King River Resources Ltd (ASX: KRR)</strong>:</p>\n<h3><strong>Exploration Update Highlights</strong></h3>\n<ul>\n<li><strong>Kurundi RC Drilling (April 2025):</strong>  </li>\n<li>New mineralized structure intersected <strong>300m NE of Kurundi Main</strong>, with highlight:  <ul>\n<li><strong>4m @ 1.43g/t Au (inc. 2m @ 2.79g/t Au)</strong> in hole TTRC188.  </li>\n</ul>\n</li>\n<li><strong>Kurundi Main Zone</strong>: Confirmed extensions but no significant high grades in deeper drilling.  </li>\n<li>\n<p>Structural complexity noted in southern high-grade zone, suggesting displaced mineralization.  </p>\n</li>\n<li>\n<p><strong>Kuiper IOCG Targets (Soil Sampling):</strong>  </p>\n</li>\n<li>Promising geochemical anomalies (Au, Cu, Bi, As) over coincident gravity/magnetic targets.  </li>\n<li><strong>Bismuth anomaly</strong> at Kuiper West aligns with gravity target, supporting IOCG potential.  </li>\n<li>\n<p><strong>Drilling planned to commence July 2025</strong>.  </p>\n</li>\n<li>\n<p><strong>Upcoming Exploration</strong>:  </p>\n</li>\n<li>Next phase of drilling at <strong>Kuiper</strong> and further target generation across Tennant Creek tenements.  </li>\n<li>Ionic leach soil sampling to refine priority targets (e.g., Rover East, Pioneer, Barkly).  </li>\n</ul>\n<h3><strong>Key Implications</strong></h3>\n<ul>\n<li><strong>Trading Catalyst</strong>: Positive drill results (new structure at Kurundi) and imminent drilling at Kuiper may impact sentiment.  </li>\n<li><strong>Exploration Upside</strong>: Kuiper\u2019s IOCG potential and Kurundi\u2019s structural extensions warrant monitoring for future resource growth.  </li>\n</ul>\n<h3><strong>Excluded</strong>:</h3>\n<ul>\n<li>Routine operational details, JORC compliance tables, and non-material assay data.  </li>\n</ul>\n<p><strong>Summary</strong>: Focus on Kurundi\u2019s new gold intercept and Kuiper\u2019s IOCG pathfinders, with drilling pending. No capital or liquidity impacts noted.</p>",
    "usage": {
      "prompt_tokens": 20358,
      "completion_tokens": 404,
      "total_tokens": 20762,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:35:41.399481"
  },
  {
    "ticker": "EGL",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968835",
    "id": "02968835",
    "pages": 3,
    "price_sensitive": false,
    "date": "20250714",
    "time": "0822",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrnfh8y5zyqq.pdf",
    "summary": "<p>No material information identified.  </p>\n<p><em>(Note: Executive appointments, unless accompanied by significant strategic shifts, remuneration details, or immediate financial implications, are generally not considered material for trading or capital markets decisions.)</em></p>",
    "usage": {
      "prompt_tokens": 1312,
      "completion_tokens": 41,
      "total_tokens": 1353,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:34:27.396135"
  },
  {
    "ticker": "NCC",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968838",
    "id": "02968838",
    "pages": 5,
    "price_sensitive": false,
    "date": "20250714",
    "time": "0822",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrnmpzzt316g.pdf",
    "summary": "<ul>\n<li><strong>Buy-back Type</strong>: On-market buy-back of convertible bonds (NCCGA)  </li>\n<li><strong>Maximum Buy-back</strong>: 23,000 securities (10% of total 230,000 outstanding)  </li>\n<li><strong>Broker</strong>: Taylor Collison Limited  </li>\n<li><strong>Currency</strong>: AUD  </li>\n<li><strong>Timing</strong>: 16/7/2025 to 15/7/2026  </li>\n<li><strong>Approval</strong>: No security holder approval required</li>\n</ul>",
    "usage": {
      "prompt_tokens": 971,
      "completion_tokens": 90,
      "total_tokens": 1061,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:33:53.309381"
  },
  {
    "ticker": "LOT",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968837",
    "id": "02968837",
    "pages": 5,
    "price_sensitive": true,
    "date": "20250714",
    "time": "0822",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrnkn9dcg2b7.pdf",
    "summary": "<p><strong>Key Material Information:</strong>  </p>\n<ul>\n<li><strong>Project Update:</strong>  </li>\n<li>Kayelekera uranium mill refurbishment completed, SAG mill restarted.  </li>\n<li>Hot commissioning underway for crushing, grinding, and leach circuits.  </li>\n<li>\n<p>First uranium oxide (U3O8) production expected this quarter.  </p>\n</li>\n<li>\n<p><strong>Financial Position:</strong>  </p>\n</li>\n<li><strong>Unaudited cash balance (30 June 2025): A$77.3M</strong> (primarily AUD &amp; USD-denominated).  </li>\n<li>No debt drawn; conditional working capital facilities remain undrawn.  </li>\n</ul>\n<p><em>Note: Operational progress supports near-term production target, but no new capital markets activity (e.g., raising, guidance change) disclosed.</em></p>",
    "usage": {
      "prompt_tokens": 2415,
      "completion_tokens": 146,
      "total_tokens": 2561,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:34:10.397515"
  },
  {
    "ticker": "ASN",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968839",
    "id": "02968839",
    "pages": 9,
    "price_sensitive": true,
    "date": "20250714",
    "time": "0822",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrnptv0dyll0.pdf",
    "summary": "<p><strong>Material Information Summary (Anson Resources Ltd - ASX:ASN):</strong><br />\n- <strong>Key Development</strong>: Bulk shipment (2+ tons) of lithium-rich brine sent to POSCO for test work as part of due diligence for a <strong>planned demonstration plant</strong> at Green River Lithium Project (Utah, USA).<br />\n- <strong>Outcome Timeline</strong>: Test results expected to inform engineering design and cost estimates by <strong>December 2025</strong> (per non-binding MoU).<br />\n- <strong>Technology Highlight</strong>: Brine pre-treated using <strong>chemical-free process</strong> to remove iron (Fe), previously validated in pilot tests.  </p>\n<p><em>No capital raising, financials, or immediate trading catalysts identified.</em></p>",
    "usage": {
      "prompt_tokens": 4605,
      "completion_tokens": 139,
      "total_tokens": 4744,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:34:00.798850"
  },
  {
    "ticker": "MI6",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968834",
    "id": "02968834",
    "pages": 23,
    "price_sensitive": false,
    "date": "20250714",
    "time": "0822",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrncf3m89ff6.pdf",
    "summary": "<h3>Project Update Summary (Bullabulling Gold Project)</h3>\n<h4><strong>Key Highlights (Material for Investors):</strong></h4>\n<ul>\n<li><strong>Pre-Feasibility Study (PFS) underway</strong>, targeting <strong>first production in CY2028</strong>.  </li>\n<li><strong>Mineral Resource Estimate update on track for Q4 CY2025</strong> (current resource: <strong>60Mt @ 1.2g/t Au for 2.3Moz</strong>).  </li>\n<li><strong>80,000m drill program ongoing</strong>, focusing on extensional and infill drilling.  </li>\n<li><strong>Metallurgical test work confirms free-milling gold</strong>, with recoveries of <strong>89\u201393% at 75-micron grind size</strong>. Further optimization planned.  </li>\n<li><strong>Approvals pathway simplified</strong>: No material environmental impediments identified; granted Mining Leases in place.  </li>\n<li><strong>Fully funded</strong> for planned activities through to <strong>Final Investment Decision (FID) in 2027</strong>.  </li>\n</ul>\n<h4><strong>Next Milestones:</strong></h4>\n<ul>\n<li><strong>PFS completion</strong>: Mid-CY2026  </li>\n<li><strong>Definitive Feasibility Study (DFS)</strong>: Q1 CY2027  </li>\n</ul>\n<p><em>No capital raising, financial figures, or trading-sensitive timetables disclosed.</em></p>",
    "usage": {
      "prompt_tokens": 15304,
      "completion_tokens": 245,
      "total_tokens": 15549,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:36:09.834146"
  },
  {
    "ticker": "BC8",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968836",
    "id": "02968836",
    "pages": 6,
    "price_sensitive": false,
    "date": "20250714",
    "time": "0822",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrnhk05vh77p.pdf",
    "summary": "<p><strong>Material Information Summary (Black Cat Syndicate ASX Announcement \u2013 14 July 2025):</strong>  </p>\n<ol>\n<li><strong>Belvedere Deposit Acceleration:</strong>  </li>\n<li>High-grade gold deposit (Resource: <strong>30koz @ 6.6g/t Au</strong>) to be fast-tracked into production.  </li>\n<li>Initial target: <strong>122kt @ 5.1g/t for 20koz</strong>, integrated into Paulsens\u2019 Restart Study.  </li>\n<li>\n<p>Mining approvals submitted, expected in <strong>~6 months</strong>.  </p>\n</li>\n<li>\n<p><strong>Operational Impact:</strong>  </p>\n</li>\n<li>Accelerated mining to utilize spare capacity at Paulsens\u2019 processing plant (operating at <strong>80% capacity</strong>).  </li>\n<li>\n<p>Underground drilling post-commencement aims to expand Resources/Reserves.  </p>\n</li>\n<li>\n<p><strong>Exploration Timetable (Near-Term Catalysts):</strong>  </p>\n</li>\n<li><strong>Jul\u2013Sep 2025</strong>: Surface drilling at Kal East (Fingals).  </li>\n<li><strong>Aug\u2013Oct 2025</strong>: Drilling at Paulsens West Seismic target (EIS co-funded).  </li>\n<li>\n<p><strong>Aug\u2013Sep 2025</strong>: Antimony drilling at Mt Clement (EIS co-funded).  </p>\n</li>\n<li>\n<p><strong>Resource/Reserve Context (Key Metrics):</strong>  </p>\n</li>\n<li><strong>Paulsens Resource</strong>: 4.3Mt @ 4.0g/t Au for <strong>548koz</strong> (incl. Belvedere).  </li>\n<li><strong>Kal East Resource</strong>: 18.8Mt @ 2.1g/t Au for <strong>1,294koz</strong>.  </li>\n<li><strong>Group Reserve</strong>: 330koz Au (Paulsens: 87koz @ 4.3g/t; Kal East: 243koz @ 2.0g/t).  </li>\n</ol>\n<p><strong>Excluded</strong>: Director commentary, general corporate details, and non-material operational timelines.</p>",
    "usage": {
      "prompt_tokens": 5443,
      "completion_tokens": 379,
      "total_tokens": 5822,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:33:00.002835"
  },
  {
    "ticker": "IFT",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968812",
    "id": "02968812",
    "pages": 2,
    "price_sensitive": false,
    "date": "20250714",
    "time": "0750",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrlpl4zvvyw0.pdf",
    "summary": "<ul>\n<li><strong>Director Trading Disclosure</strong>: Jason Boyes (Director &amp; CEO of Infratil Limited) acquired <strong>45,393 IFT ordinary shares</strong> on-market between <strong>7-Jul-25 and 11-Jul-25</strong> at prices ranging from <strong>NZ$10.92251 to NZ$10.9584 per share</strong>.  </li>\n<li><strong>Total consideration</strong>: <strong>~NZ$497,329.75</strong>.  </li>\n<li><strong>Post-transaction holdings</strong>: <strong>2,427,830 shares</strong> (beneficially owned).  </li>\n</ul>\n<p><em>No material impact on capital structure or liquidity identified.</em></p>",
    "usage": {
      "prompt_tokens": 947,
      "completion_tokens": 118,
      "total_tokens": 1065,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:09:46.891849"
  },
  {
    "ticker": "PEB",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968811",
    "id": "02968811",
    "pages": 10,
    "price_sensitive": true,
    "date": "20250714",
    "time": "0730",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrlhgrd1s0s7.pdf",
    "summary": "<h3><strong>Capital Raising Announcement</strong></h3>\n<ul>\n<li><strong>Structure</strong>: Placement + Share Purchase Plan (SPP)  </li>\n<li><strong>Placement</strong>: AUD $16.1 million raised (oversubscribed) at $0.10/share (18% premium to 20-day VWAP).  </li>\n<li><strong>SPP</strong>: AUD $5 million targeted (potential oversubscription); retail shareholders eligible.  </li>\n<li><strong>Key Dates</strong>:  </li>\n<li><strong>Annual Meeting</strong>: 6 August 2025 (shareholder approval for placement required).  </li>\n<li><strong>SPP Opening</strong>: Mid-July 2025 (conditional on placement approval).  </li>\n</ul>\n<h3><strong>Operational Highlights (Q1 FY26)</strong></h3>\n<ul>\n<li><strong>US Test Volumes</strong>:  </li>\n<li>Total Laboratory Throughput (TLT): <strong>6,900 tests</strong> (down 8.9% QoQ).  </li>\n<li>US TLT: <strong>5,717 tests</strong> (down 11.9% QoQ) due to transition from <em>Detect</em> to <em>Triage</em>.  </li>\n<li><em>Triage</em> adoption: <strong>77% of US tests</strong> in June 2025 (vs. 22% in Q4 FY25).  </li>\n<li><strong>Asia Pacific Growth</strong>: <strong>1,183 tests</strong> (up 8.8% QoQ).  </li>\n<li><strong>Medicare Reconsideration</strong>: Positive discussions with Novitas; reconsideration request submitted for <em>Triage</em> (based on AUA Guideline inclusion and STRATA study).  </li>\n</ul>\n<h3><strong>Material Developments</strong></h3>\n<ol>\n<li><strong>Triage Plus Progress</strong>:  </li>\n<li>Analytical Validation published (Diagnostics, July 2025); supports Medicare reconsideration.  </li>\n<li>Draft Medicare price: <strong>US$1,018/test</strong> (vs. $760 for <em>Triage</em>). Pending DRIVE study peer review (submitted June 2025).  </li>\n<li><strong>AUA Guideline Impact</strong>:  </li>\n<li><em>Triage</em> holds \"Grade A\" evidence rating; drives payer negotiations (e.g., Optum VACCN coverage at Medicare rate).  </li>\n<li><strong>Cash Runway</strong>: Capital raise extends runway <strong>&gt;12 months</strong> without Medicare coverage.  </li>\n</ol>\n<hr />\n<p><strong>Omitted</strong>: Routine details on director re-elections, clinical study timelines (non-near-term), and regional breakdowns.<br />\n<strong>Key Focus</strong>: Capital structure, volume trends, Medicare strategy, and <em>Triage Plus</em> commercialization.</p>",
    "usage": {
      "prompt_tokens": 7214,
      "completion_tokens": 495,
      "total_tokens": 7709,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:10:10.943634"
  },
  {
    "ticker": "SNZ",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968810",
    "id": "02968810",
    "pages": 6,
    "price_sensitive": false,
    "date": "20250714",
    "time": "0730",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrlf7nq5f4mq.pdf",
    "summary": "<ul>\n<li><strong>Announcement Type:</strong> Employee incentive scheme securities issuance  </li>\n<li><strong>Securities Issued:</strong> 192,360 ordinary fully paid shares (ASX: SNZ)  </li>\n<li><strong>Issue Price:</strong> NZD 11.8757 per share  </li>\n<li><strong>Issue Date:</strong> 14/07/2025  </li>\n<li><strong>Ranking:</strong> Equally with existing shares  </li>\n<li><strong>Post-Issue Issued Capital:</strong> 241,123,378 ordinary shares on issue  </li>\n<li><strong>Key Management Personnel (KMP) Allocations:</strong>  </li>\n<li>Scott Scoullar: 84 shares  </li>\n<li>Margaret Warrington: 84 shares  </li>\n</ul>\n<p><em>No material impact on capital structure or liquidity expected (minor issuance under incentive scheme).</em></p>",
    "usage": {
      "prompt_tokens": 1489,
      "completion_tokens": 150,
      "total_tokens": 1639,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:09:52.172406"
  }
]